Differential effects of BTK inhibitors ibrutinib and zanubrutinib on NK-cell effector function in patients with mantle cell lymphoma

Thijs WH Flinsenberg; Charnelle C Tromedjo; Nan Hu; Ye Liu; Yin Guo; Kevin YT Thia; Tahereh Noori; Xiaomin Song; Han X Aw Yeang; Daniela G Tantalo; Sasanka Handunnetti; John F Seymour; Andrew W Roberts; David Ritchie; Rachel Koldej; Paul J Neeson; Lai Wang; Joseph A Trapani; Constantine S Tam; Ilia Voskoboinik

Journal article

Differential effects of BTK inhibitors ibrutinib and zanubrutinib on NK-cell effector function in patients with mantle cell lymphoma

Thijs WH Flinsenberg, Charnelle C Tromedjo, Nan Hu, Ye Liu, Yin Guo, Kevin YT Thia, Tahereh Noori, Xiaomin Song, Han X Aw Yeang, Daniela G Tantalo, Sasanka Handunnetti, John F Seymour, Andrew W Roberts, David Ritchie, Rachel Koldej, Paul J Neeson, Lai Wang, Joseph A Trapani, Constantine S Tam, Ilia Voskoboinik

Haematologica | FERRATA STORTI FOUNDATION | Published : 2020

DOI: 10.3324/haematol.2019.220590

University of Melbourne Researchers

Constantine Tam Author Medicine - St Vincent's Hospital

Han Aw Yeang Author

Paul Neeson Author The Sir Peter MacCallum Department of Oncology

John Seymour Author Medicine - St Vincent's Hospital

David Ritchie Author Medicine - Royal Melbourne Hospital

Grants

Awarded by EMBO

Funding Acknowledgements

we acknowledge the support of EMBO (ALTF 219-2017 for TF), CLL Global Research Foundation for CT and IV, National Health and Medical Research Council for IV and JT.